Back
Nutex Health Quote, Financials, Valuation and Earnings
The dark truth about AI
Click here to learn more...
Sell
50
NUTX
Nutex Health
Last Price:
34.39
Seasonality Move:
6.33%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Nutex Health Price Quote
$34.39
-0.58 (2.14%)
(Updated: December 14, 2024 at 5:45 AM ET)
Nutex Health Key Stats
Sell
50
Nutex Health (NUTX)
is a Sell
Day range:
$32.42 - $35.06
52-week range:
$4.16 - $41.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.43
P/B ratio:
3.03%
Volume:
24K
Avg. volume:
61.9K
1-year change:
26.98%
Market cap:
$183.1M
Revenue:
$247.6M
EPS:
$-10.79
How Much Does Nutex Health Make?
-
How Much Are Nutex Health's Sales Annually?
NUTX Revenues are $247.6M -
How Much Profit Does Nutex Health's Make A Year?
NUTX net income is -$45.8M
Is Nutex Health Growing As A Company?
-
What Is Nutex Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.26% -
What Is Nutex Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Nutex Health Stock Price Performance
-
Did Nutex Health Stock Go Up Last Month?
Nutex Health share price went up by 7.24% last month -
Did NUTX's Share Price Rise Over The Last Year?
NUTX share price rose by 26.98% over the past 1 year
What Is Nutex Health 52-Week High & Low?
-
What Is Nutex Health’s 52-Week High Share Price?
Nutex Health has traded as high as $41.44 over the past 52 weeks -
What Is Nutex Health’s 52-Week Low Share Price?
Nutex Health has traded as low as $4.16 over the past 52 weeks
Nutex Health Price To Free Cash Flow
-
Is Nutex Health Stock Overvalued?
Nutex Health is trading at a price to free cash flow ratio of 6.16 -
Is Nutex Health Stock Undervalued?
Nutex Health EV to Free Cash Flow ratio is 9.69 -
What Is Nutex Health’s Price Earnings Growth Ratio?
NUTX PEG ratio is 0.00 -
Is Nutex Health Trading At A Premium To Earnings?
Nutex Health EV to EBIT ratio is 0.00
Is It Risky To Buy Nutex Health?
-
How Much Debt Does Nutex Health Have?
Total long term debt quarterly is $40.7M -
How Much Cash Does Nutex Health Have?
Cash and short term investments quarterly total is $46.9M -
What Is Nutex Health’s Book Value Per Share?
Book value per share is 11.59
Is Nutex Health Cash Flow Positive?
-
What Is NUTX Cash Flow From Operations?
Cash flow from operations (TTM) is $21.3M -
What Is Nutex Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $162.8K -
What Is Nutex Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.4M
Nutex Health Return On Invested Capital
-
Is Management Doing A Good Job?
NUTX return on invested capital is -32.79% -
What Is Nutex Health Return On Assets?
ROA measures how assets are converting to revenues and is -9.6% -
What Is NUTX Return On Equity?
ROE is a measure of profitability and is -48.3%
Nutex Health Earnings Date & Stock Price
-
What Is Nutex Health's Stock Price Today?
A single share of NUTX can be purchased today for 34.97 -
What Is Nutex Health’s Stock Symbol?
Nutex Health trades on the nasdaq under the ticker symbol: NUTX -
When Is Nutex Health’s Next Earnings Date?
The next quarterly earnings date for Nutex Health is scheduled on March 14, 2025 -
When Is NUTX's next ex-dividend date?
Nutex Health's next ex-dividend date is December 14, 2024 -
How To Buy Nutex Health Stock?
You can buy Nutex Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Nutex Health Competitors
-
Who Are Nutex Health's Competitors?
Below is a list of companies who compete with Nutex Health or are related in some way:
Nutex Health Dividend Yield
-
What Is NUTX Dividend Yield?
Nutex Health’s dividend yield currently is 0% -
What Is Nutex Health’s Payout Ratio?
Nutex Health’s payout ratio is -11.03% -
When Did Nutex Health Last Pay A Dividend?
The latest dividend pay date is December 14, 2024 -
What Is Nutex Health’s Dividend Per Share?
Nutex Health pays a dividend of $0.00 per share
Nutex Health Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -213.9% |
| Revenue: | 25.62% | 7.61% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 55.33 |
| Upside from Last Price: | 58.23% |